Monoprice 10594 Graphic Drawing Tablet, 10 X 6.25 Inches

Manufacturer part number: 10594

Get unsurpassed accuracy and performance from this 10 x 6.25-inch Graphic Drawing Tablet from Monoprice!

This tablet features a 4000 lines per inch (LPI) drawing resolution, a 200 RPS report rate, and 2048 levels of pressure sensitivity. It has eight user assignable Express Keys on the left side of the drawing area. It also features sixteen user assignable Hot Cells along the upper edge of the drawing surface. The Express Keys and Hot Cells can be assigned to input specific keystroke combinations, launch applications, open web pages, send email, or to emulate a specific mouse function (e.g., left-click).

The tablet comes with driver/software utilities for use with Windows® (XP and later) and Mac® OS X® (10.4.x and later). It uses a USB interface and is physically compatible with Linux®, though Linux drivers are not included.

Note: Starting with v9.0 of the Windows driver (Jul 16, 2014, linked below) the ability to flip the tablet so that the Express Keys are on the right side has been added.

Support Files:

User's Manual for Windows (Oct 30, 2013)
User's Manual for Mac OS X (Oct 30, 2013)
(Mar 4, 2016)
(Sep 30, 2015)
(Apr 16, 2015)
(Jul 16, 2014)
(Apr 4, 2014)
(Oct 30, 2013)
(Oct 30, 2013)
(Oct 30, 2013)

Microsoft® and Windows® are registered trademarks of Microsoft Corporation in the United States and/or other countries.

Apple®, Mac®, and OS X® are trademarks of Apple Inc., registered in the U.S. and other countries.

Linux® is the registered trademark of Linus Torvalds in the U.S. and other countries.

Updated Nov 21, 2019

Model	10594
Active Drawing Area	10" x 6.25"
Drawing Resolution	4000 lines per inch
Report Rate	200 reports/second
Pressure Sensitivity	2048 levels
Express Keys	8
Hot Cells	16
Windows® Compatibility	XP and later
Mac® OS X® Compatibility	10.4.x and later

Attention CA Residents: Prop 65 Warning

WARNING: This product can expose you to chemicals which are known to the State of California to cause cancer, birth defects, or other reproductive harm. For more information, go to www.p65warnings.ca.gov.